Literature DB >> 20605317

A critical analysis of orthotopic bladder substitutes in adult patients with bladder cancer: is there a perfect solution?

Wassim Kassouf1, Richard E Hautmann, Bernard H Bochner, Seth P Lerner, Renzo Colombo, Alexandre Zlotta, Urs E Studer.   

Abstract

CONTEXT: Orthotopic bladder substitute (OBS) has been popularized over the past 2 decades as a diversion following radical cystectomy for invasive bladder cancer. Various reports, mostly single-center experiences, are published on patients with OBS.
OBJECTIVE: This study reviews the literature regarding indications, postoperative care, complications, quality-of-life measures, as well as functional and oncologic outcomes that have been published on patients with OBS. EVIDENCE ACQUISITION: An English-language literature review of the Medline database (1990 to January 2010) of published data on patients with OBS following radical cystectomy for bladder cancer was undertaken. Articles that included surgery for noncancer etiology were excluded. EVIDENCE SYNTHESIS: Indications and patient selection criteria have significantly widened over the past 2 decades. Comparable oncologic data have been reported between patients with OBS versus other diversions. Secondary urethral tumors seem less common in patients with OBS compared with those with conduits or continent cutaneous diversions. Durable daytime and nocturnal continence is achieved in 85-90% and 60-80%, respectively. Continence is inferior in elderly patients with OBS. Urinary retention remains significant in the female patients, ranging from 25% to 50%. Complications including electrolyte disturbances, altered sensorium and drug metabolism, mucus retention, rupture, urinary tract infections, and upper tract deterioration are reviewed.
CONCLUSIONS: Indications for OBS following radical cystectomy in patients with invasive bladder cancer have significantly widened over the past 2 decades. An OBS should be offered to both male and female patients in the absence of contraindications. Good long-term functional and oncologic outcomes can be achieved in patients with OBS treated in high-volume institutions by experienced surgeons with specific knowledge in the field. Preoperative patient information, patient selection, surgical techniques, and careful postoperative follow-up are the cornerstones to achieve good long-term results. (c) 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20605317     DOI: 10.1016/j.eururo.2010.05.023

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  15 in total

Review 1.  [Treatment of bladder cancer. Value of radical prostate-sparing cystectomy].

Authors:  A Heidenreich; D Porres; D Pfister
Journal:  Urologe A       Date:  2012-06       Impact factor: 0.639

Review 2.  Parastomal hernia following cystectomy and ileal conduit urinary diversion: a systematic review.

Authors:  Sunil K Narang; Nasra N Alam; Nick J Campain; Samir Pathak; John S McGrath; Ian R Daniels; Neil J Smart
Journal:  Hernia       Date:  2016-12-26       Impact factor: 4.739

3.  Outcomes of a bladder preservation technique in female patients undergoing pelvic exenteration surgery for advanced gynaecological tumours.

Authors:  Bernhard Liedl; Wael Y Khoder; Brigitte Ruhdorfer-Metz; Christian G Stief; Raphaela Waidelich
Journal:  Int Urogynecol J       Date:  2014-03-15       Impact factor: 2.894

4.  Tips and tricks for intracorporeal robot-assisted urinary diversion.

Authors:  J W Collins; A Hosseini; P Sooriakumaran; T Nyberg; R Sanchez-Salas; C Adding; Martin C Schumacher; N P Wiklund
Journal:  Curr Urol Rep       Date:  2014-11       Impact factor: 3.092

5.  Perugia ileal neobladder: functional results and complications.

Authors:  Massimo Porena; Luigi Mearini; Alessandro Zucchi; Michele Del Zingaro; Ettore Mearini; Antonella Giannantoni
Journal:  World J Urol       Date:  2012-11-13       Impact factor: 4.226

6.  Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015.

Authors:  Wassim Kassouf; Armen Aprikian; Peter Black; Girish Kulkarni; Jonathan Izawa; Libni Eapen; Adrian Fairey; Alan So; Scott North; Ricardo Rendon; Srikala S Sridhar; Tarik Alam; Fadi Brimo; Normand Blais; Chris Booth; Joseph Chin; Peter Chung; Darrel Drachenberg; Yves Fradet; Michael Jewett; Ron Moore; Chris Morash; Bobby Shayegan; Geoffrey Gotto; Neil Fleshner; Fred Saad; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2016-02-08       Impact factor: 1.862

Review 7.  [Urinary diversion in elderly patients].

Authors:  M Spahn; S Boxler
Journal:  Urologe A       Date:  2015-12       Impact factor: 0.639

8.  Quality of life in women undergoing urinary diversion for bladder cancer: results of a multicenter study among long-term disease-free survivors.

Authors:  Mauro Gacci; Omar Saleh; Tommaso Cai; John L Gore; Carolina D'Elia; Andrea Minervini; Lorenzo Masieri; Claudia Giannessi; Michele Lanciotti; Virginia Varca; Alchiede Simonato; Sergio Serni; Giorgio Carmignani; Marco Carini
Journal:  Health Qual Life Outcomes       Date:  2013-03-12       Impact factor: 3.186

9.  Proactive approach to treat high-grade lamina-invasive bladder cancer.

Authors:  Anil Mandhani
Journal:  Indian J Urol       Date:  2011-04

10.  Clinical evaluation of patients treated with a detubularised isolated ureterosigmoidostomy diversion after radical cystectomy.

Authors:  Mohammed A Atta; Tamer M Abou Youssif; Ahmed F Kotb
Journal:  Arab J Urol       Date:  2014-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.